COMBINING A NOVEL DUAL RAF/MEK INHIBITOR WITH IMMUNOMODULATION TO PROMOTE AN ANTI-TUMOR RESPONSE

被引：0
|
作者：
Dong, Lauren [1 ]
Choi, Hyejin [1 ]
Budhu, Sadna [1 ]
Schulze, Isabell [1 ]
Mehanna, Nezar [1 ]
Rosen, Neal [1 ]
Merghoub, Taha [1 ]
Wolchok, Jedd [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2021年 / 9卷
关键词：
D O I：
10.1136/jitc-2021-SITC2021.604
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
604
引用
收藏
页码：A634 / A634
页数：1
相关论文
共 50 条
  • [1] Combining a novel dual RAF/MEK inhibitor with immunomodulation to promote an anti-tumor response
    Dong, Lauren
    Choi, Hyejin
    Budhu, Sadna
    Mehanna, Nezar
    Falik, Nouraiz
    Rosen, Neal
    Merghoub, Taha
    Wolchok, Jedd D.
    JOURNAL OF IMMUNOLOGY, 2020, 204 (01):
  • [2] Combining a novel MEK inhibitor with immunomodulation to promote an anti-tumor response
    Dong, Lauren
    Choi, Hyejin
    Budhu, Sadna
    Schulze, Isabell
    Verma, Svena
    Mehanna, Nezar
    Rosen, Neal
    Merghoub, Taha
    Wolchok, Jedd
    CANCER RESEARCH, 2022, 82 (12)
  • [3] Discovery of Novel AKT Inhibitors with Enhanced Anti-Tumor Effects in Combination with the MEK Inhibitor
    Dumble, Melissa
    Crouthamel, Ming-Chih
    Zhang, Shu-Yun
    Schaber, Michael
    Levy, Dana
    Robell, Kimberly
    Liu, Qi
    Figueroa, David J.
    Minthorn, Elisabeth A.
    Seefeld, Mark A.
    Rouse, Meagan B.
    Rabindran, Sridhar K.
    Heerding, Dirk A.
    Kumar, Rakesh
    PLOS ONE, 2014, 9 (06):
  • [4] In situ immunomodulation of tumors with biosynthetic bacteria promote anti-tumor immunity
    Lin, Zhongda
    Meng, Fanqiang
    Ma, Yumeng
    Zhang, Chi
    Zhang, Zhirang
    Yang, Zhaoxin
    Li, Yuan
    Hou, Linlin
    Xu, Yuzhong
    Liang, Xin
    Zhang, Xudong
    BIOACTIVE MATERIALS, 2024, 32 : 12 - 27
  • [5] A novel Raf kinase inhibitor blocks the Raf/MEK/ERK pathway in tumor cells.
    Wilhelm, S
    Kennure, N
    Housley, T
    Katz, M
    Wood, J
    Lyons, J
    Taylor, R
    Knepper, M
    Roscoe, W
    Bollag, G
    CLINICAL CANCER RESEARCH, 2000, 6 : 4547S - 4547S
  • [6] Anti-tumor effects of a novel MEK inhibitor in combination with cytotoxic chemotherapy in human melanoma cell lines
    Denton, Cathrine L.
    Gustafson, Daniel L.
    CANCER RESEARCH, 2006, 66 (08)
  • [7] Novel Allosteric RAF/MEK Inhibitor in the Treatment of Rhabdomyosarcoma
    Nakagawa, Norio
    Kikuchi, Ken
    Yagyu, Shigeki
    Iehara, Tomoko
    Toshiyuki, Sakai
    Hosoi, Hajime
    PEDIATRIC BLOOD & CANCER, 2018, 65 : S27 - S28
  • [8] Anti-tumor activity of the novel angiogenesis inhibitor anginex
    Dings, RPM
    van der Schaft, DWJ
    Hargittai, B
    Haseman, J
    Griffioen, AW
    Mayo, KH
    CANCER LETTERS, 2003, 194 (01) : 55 - 66
  • [9] Radiotherapy-Mediated Immunomodulation and Anti-Tumor Abscopal Effect Combining Immune Checkpoint Blockade
    Zhao, Xinrui
    Shao, Chunlin
    CANCERS, 2020, 12 (10) : 1 - 20
  • [10] IK-595, a best-in-class MEK-RAF complex inhibitor, drives broad and potent anti-tumor activity in RAS/RAF-driven tumors Abstract
    Haines, Eric
    Catterall, Rachel
    De Jesus, Victor
    Li, Bin
    Wessel, Sarah R.
    Cavanaugh, Jill
    Burke, Michael
    Manna, Joseph D.
    Zavidij, Okzana
    Yang, Ao
    Xu, Lan
    Santillana, Sergio
    Ecsedy, Jeffrey
    Zhang, X. Michelle
    Ruppel, Sabine K.
    MOLECULAR CANCER THERAPEUTICS, 2023, 22 (12)
12345